Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201420152016201720182019
Sales23 00623 92327 88930 00431 06532 344
EBITDA8 0457 0289 63210 21510 56711 105
Operating profit (EBIT)6 5945 7297 7718 3278 7079 283
Pre-Tax Profit (EBT)2 96810 5261 9396 3827 3067 889
Net income2 7568 4229124 2524 7245 113
P/E ratio24,37,9783,119,116,515,5
EPS (GBp )56,717218,885,598,6105
Dividend per Share (GBp )80,080,080,080,080,481,5
Yield5,81%5,83%5,12%4,91%4,94%5,00%
Reference price (GBp )1376137315621629.51629.51629.5
Announcement Date02/04/2015
03:18pm
02/03/2016
12:00pm
02/08/2017
12:35pm
---
Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201420152016201720182019
Debt14 37710 72713 80413 98313 29512 178
Finance------
Operating income (EBITDA)8 0457 0289 63210 21510 56711 105
Leverage
(Debt/EBITDA)
1,79x1,53x1,43x1,37x1,26x1,10x
Capital Expenditure1 1881 3801 5431 8001 7291 775
Book Value Per Share (BVPS)87,6 PNC106 PNC22,9 PNC51,3 PNC71,1 PNC93,3 PNC
Cash Flow per Share108 PNC53,2 PNC132 PNC139 PNC149 PNC156 PNC
Announcement Date02/04/2015
03:18pm
02/03/2016
12:00pm
02/08/2017
12:35pm
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Advertisement
Financial Ratios

Size 2017e 2018e
Capitalization 80 130 M GBP -
Entreprise Value (EV) 94 113 M GBP 93 425 M GBP
Valuation 2017e 2018e
P/E ratio (Price / EPS) 19,1x 16,5x
Capitalization / Revenue 2,67x 2,58x
EV / Revenue 3,14x 3,01x
EV / EBITDA 9,21x 8,84x
Yield (DPS / Price) 4,91% 4,94%
Price to book (Price / BVPS) 31,7x 22,9x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 27,8% 28,0%
operating Leverage (Delta EBIT / Delta Sales) 0,94x 1,29x
Net Margin (Net Profit / Revenue) 14,2% 15,2%
ROA (Net Profit / Asset) 9,41% 10,3%
ROE (Net Profit / Equities) 322% 230%
Rate of Dividend 93,5% 81,6%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   6,00% 5,56%
Cash Flow / Sales 22,8% 23,6%
Capital Intensity (Assets / Sales) 1,51x 1,47x
Financial Leverage (Net Debt / EBITDA) 1,37x 1,26x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend